Furthermore, CatB promotes tumor progression by inducing EMT in which higher CatB protein levels are linked with a more invasive mesenchymal cell phenotype (Fig. 1A) [142] and with EMT activators through the E‐box element in the CatB promoter [143]. Here, TYRP1 is linked to neoplasm.